Company Overview
Company Name
HEALIOS K.K.
Representative
Hardy TS Kagimoto, MD, Chairman and CEO
Establishment
February 24, 2011
Paid in Capital
4,489 million yen (As of April 30, 2026)
Head Office
Toranomon Hills Business Tower 15F, 1 Chome 17-1, Toranomon, Minato-Ku, Tokyo 105-6415, Japan
Number of Employees
82 (As of June 30, 2026)
Business
Research, development and manufacturing of cell therapy/ regenerative medicine products
Research Institution
Kobe Research Institute
Affiliated Company
Sighregen Co., Ltd.
(Joint Venture with Sumitomo Pharma Co., Ltd.)
Subsidiaries
・Healios NA Inc.
（Established in February 2018）
・Saisei Ventures LLC
（Established in January 2021 as a venture fund investment advisor）
・Saisei Capital Ltd.
（Established in January 2021 as a venture fund general partner）
・Saisei Bioventures, L.P.
（Established in January 2021 as a venture fund limited partnership）
・ProcellCure Inc.（Established in July 2023 to promote development of ARDS）
Access
Tokyo Office
Address
Toranomon Hills Business Tower 15F, 1Chome 17-1, Toranomon, Minato-Ku, Tokyo
105-6415, Japan
Tokyo Metro Hibiya Line
Direct access from ”Toranomon Hills Station”
Tokyo Metro Ginza Line
Direct access from ”Toranomon Station”
Kobe Research Institute
Address
Kobe KIMEC Center Bldg. 3F 1-5-2 Minatojima-Minamimachi Chuo-ku, Kobe, Hyogo 650-0047
Port Liner Monorail
2-minute walk from Iryo Center Station